The Power of Data Analytics During the Opioid Crisis and COVID-19 “Twindemic”
While COVID-19 disrupted the lives of nearly every American, those suffering from substance abuse disorder have had been disproportionately affected by the drastic changes in how we work, socialize, and seek care. According to recent findings from the CDC, opioid overdoses and deaths have accelerated. More than 40 states have reported increases in opioid-related mortality, particularly from fentanyl or fentanyl-like substances.
While healthcare providers have made program and policy adjustments in response to COVID safety protocols (e.g. more accessible telemedicine), we’ve also seen impressive advancements in the application of data sharing and data analytics to address the “twindemic.”
In her recent article for MedCity News, Qlarion’s Senior Director of Healthcare Services, Lyd Paull-Flores, shares how healthcare leaders can improve community response and mitigate opioid addiction by applying a data-driven, non-punitive approach. Lyd explores how predictive analytics and data sharing can play a role in the proactive treatment and management of addiction during COVID-19 and beyond.